Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedA new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's funding/identification information. This addition documents NIH support for the trial within the record.SummaryDifference0.0%

- Check9 days agoChange DetectedSite-wide status banners indicating an outage and intermittent delays have been removed. The page now presents only the study details without the preceding service-status notices.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded a sitewide outage warning banner with a message about intermittent delays and updated the revision to v3.6.5 (replacing v3.6.4).SummaryDifference0.1%

- Check38 days agoChange DetectedThe revision label on the page updates from v3.6.3 to v3.6.4, indicating a new minor version of the page/document.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision changed from v3.6.0 to v3.6.3, updating the page's version identifier. This indicates that a newer revision of the page has been published.SummaryDifference0.0%

- Check81 days agoChange DetectedNew navigation items and guidance sections appear, including How to Read a Study Record, Common Questions, and How to Join a Study, with an explicit recruitment status update indicating no participants are being sought. The Intervention/Treatment label is reformatted and a new revision tag v3.6.0 replaces the prior version tag.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.